Document text
Principal Investigator: Brett Stewart Carver
Organization: SLOAN-KETTERING INST CAN RESEARCH
Fiscal Year: 2024
Award: $383,552
Funding agency: National Cancer Institute
PROJECT SUMMARY/ABSTRACT
Since its inception in 1999, the primary objective of the T32 Urologic Oncology Research Training
Program at Memorial Sloan Kettering Cancer Center (MSK) has been to train select urologists for
productive careers in translational research in urologic oncology. Dedicated research training in urologic
oncology is essential to the mission of the National Cancer Institute (NCI) to reduce morbidity and
mortality from genitourinary cancers, which cause about 10% of all cancer-related deaths in the United
States and which are expected to rise steadily in incidence as the population ages. For the proposed
funding period, we seek to continue our interactive, multidisciplinary research training strategy that
integrates the following: (1) a multidisciplinary faculty of basic, clinical, and translational researchers
spanning the disciplines of surgery, medicine, cancer biology and therapeutics, molecular pathology and
genetics, immunotherapy, molecular radiology, biostatistics and epidemiology, and laboratory medicine,
(2) an intensive mentored research practicum tailored to the T32 trainee’s research interests and goals,
(3) a core curriculum of required didactic and discussion-based courses to enhance the quality of the
hands-on research training, (4) structured career development workshops in grant writing and career
development awards, and (5) elective activities that will allow T32 trainees to further immerse themselves
in the world of cancer research and to network with peers and established leaders. Each year, 2 highly
committed postdoctoral trainees from the Urologic Oncology Fellowship Program at MSK are selected for
the T32 Urologic Oncology Research Training Program. They must have an MD, must have completed
residency training in urology, and must be board-eligible urologists. These 2 trainees are supported by
this T32 training grant during 2 years dedicated to urologic oncology research training, with appointment
to the 2nd year contingent on suitable progress. At the completion of their training, graduates of theT32
Urologic Oncology Research Training Program are expected to be attractive candidates for junior faculty
appointments at research-focused academic organizations. In the past 10 years, 90% of T32 trainee
graduates have matriculated to faculty positions at academic institutions and are engaged in laboratory
and/or clinical research aimed at understanding and overcoming genitourinary cancers.
Terms: <Research Training><Training Programs><Urologic Oncology>